IL36G and head and neck squamous cell carcinoma: Additionally, mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36γ, is currently undergoing clinical trials for various malignancies, including HNSCC (NCT03739931).